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Abstract
Background: Methicillin resistant Staphylococcus aureus (MRSA) are one of the most common and important pathogens, account-
ing for diverse nosocomial and community-acquired infections. The serious concern about these bacteria is the development of
antibiotic resistance.
Objectives: The present study was conducted to investigate the frequency of MRSA strains, their epidemiological and molecular
relationships and antibiotic susceptibility patterns of isolated strains from university teaching hospitals of Tabriz, Northwestern
Iran (during years 2014 and 2015).
Methods: A total of 215 non-repetitive clinical isolates of S. aureus were identified using standard methods. The MRSA isolates were
detected by the combination of phenotypic and genotypic methods. The presence of pvl gene and SCCmec types was determined by
PCR and multiplex PCR, respectively. The MRSA isolates, in which the presence of mecA gene had been confirmed by PCR, were sub-
jected to Rep-PCR analysis. Resistance to antibacterial agents was determined by disk diffusion, screening agar, and E-test methods.
Results: All S. aureus isolates were positive for nuc gene and 87 (40.5%) of them revealed the presence of mecA gene, confirming them
as MRSA. All isolates were found to be sensitive to linezolid and vancomycin. However, a reduced sensitivity of 3 MRSA isolates to
vancomycin was observed (MIC = 6 µg/mL). SCCmec type III was the most prevalent (79.31%), followed by type IVd (13.80%) and type
I (6.90%). The PVL occurrence was detected in 33 (15.35%) S. aureus isolates. The MRSA isolates could be divided to 2 main clusters,
indicating the possible clonal relatedness of MRSA isolates.
Conclusions: The MRSA isolates with SCCmec type III were the predominant MRSA strains in this area. The majority of MRSA isolates
were MDR. Linezolid and vancomycin were found as suitable antibiotics for the treatment of MRSA. The results of typing methods
indicated possible clonal relatedness among MRSA isolates. Therefore, routine infection control surveillance is necessary for the
prevention of epidemic emergence.
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1. Background
To date, 12 different types of SCCmec (I to XII) have
been described for methicillin resistant Staphylococcus au-
reus (MRSA) isolates (1). Types I-V are globally distributed,
yet the others have been limited to geographic locations
around the world (1, 2). Types I, II, III, VI, and VIII, which are
mainly associated with hospital-acquired (HA) infections
(HA-MRSA), contain genes that encode resistance to other
antimicrobials and are associated with multiple drug re-
sistance (1, 3-5). SCCmec types IV and V has commonly been
found in community-acquired (CA) methicillin-resistant
Staphylococcus aureus (CA-MRSA) strains (1, 5). Types IX and
X are associated with animals (livestock-associated (LA)
MRSA or LA-MRSA), of which type IX contains mecC (1).
Panton-valentine leukocidin (PVL) is considered one
of the important virulence factors of MRSA and Methi-
cillin Sensitive Staphylococcus aureus (MSSA) isolates re-
sponsible for acute coetaneous infections, severe chronic
osteomyelitis, deadly necrotizing pneumonia, long-term,
and intractable infections (6, 7). In the recent years, the
prevalence of PVL in S. aureus strains is increasing due to
global distribution of PVL-producing MRSA strains. The
worldwide spread of PVL-positive CA-MRSA is likely related
to continent-specific clones of PVL-positive CA-MRSA, the
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spreading of the isolates from country to country by inter-
national travel, and the emergence of new PVL-positive CA-
MRSA clones with different genetic backgrounds. On the
other hand, PVL positive CA-MRSA strains, which were ini-
tially susceptible to most anti-staphylococcal antimicro-
bial agents, have acquired new antimicrobial resistance
determinants and thus survive in various environments.
Therefore, the combination of the mecA gene and the
pvl gene would create a super adaptable S. aureus strain,
which is multidrug-resistant and capable of rapid spread-
ing around the world, which emphasizes the importance
of determining the local prevalence of PVL-positive MRSA
strains, as it can be useful in early and proper therapy for
serious MRSA infections and their management (2, 5, 6, 8).
Accurate epidemiological typing is of primary impor-
tance for the identification of MRSA strains found in hos-
pitals and communities, thereby enabling sources and
routes of transmission to be identified and controlled (9-
11).
Repetitive palindromic extragenic elements poly-
merase chain reaction (Rep-PCR) was described by Versa-
lovic et al. (11, 12). The Rep-PCR is an epidemiological typing
technique and provides an attractive system, which is
discriminative, more rapid, and cost-effective than other
molecular typing assays (11, 13, 14).
The SCCmec typing method has also been used many
times to determine outbreaks, epidemiology and lineage
of MRSA isolates, recovered from hospitals and communi-
ties (1, 5, 6).
2. Objectives
In this study, the frequency of MRSA and its antibi-
otic resistance pattern, occurrence of the pvl gene, SCCmec
types and Rep-PCR typing of MRSA isolates were deter-
mined in Tabriz, North West of Iran.
3. Methods
3.1. Isolation and Identification of Staphylococcus aureus
During a 1-year period, from February, 2014, to March,
2015, all clinical specimens of out-patients and in-patients
submitted to microbiology laboratories of educational
health care centers of Tabriz University of Medical Sciences,
in the Northwest of Iran, were screened for the presence
of S. aureus isolates by standard microbiology tests. Repet-
itive isolates from the same patient were not included in
this study.
3.2. Antibiotic Susceptibility Testing
Antibiotic susceptibility test was performed as per
the clinical and laboratory standards institute (CLSI-2014)
guidelines (15), with a panel of the following antibiotics
(MAST, Group Ltd, Merseyside, UK): oxacillin (1 µg), ce-
foxitin (30 µg), penicillin (10 U), gentamicin (10 µg),
erythromycin (15 µg), clindamycin (2 µg), rifampin (30
µg), ciprofloxacin (5 µg), trimethoprim-sulfamethoxazole
(1.25/23.75µg), and linezolid (30µg).
The minimum inhibitory concentrations (MICs) were
determined by E-test on Mueller-Hinton’s agar plates
(MHA, Merck, Germany) for oxacillin and vancomycin,
according to the manufacturer’s recommendations (Li-
ofilchem, Italy), and the breakpoints for resistance were
those defined by the clinical laboratory standards institute
(CLSI)-2014.
3.3. Agar Screening Methods
Agar screening tests for susceptibility to oxacillin and
vancomycin were performed as directed by CLSI-2014 (15).
3.4. DNA Extraction
Briefly, DNA was extracted using dodecyl sulfate
sodium salt (SDS, Merck, Germany)- proteinase K (Cinna-
Gene, Tehran, Iran) method modified with N-cetyl-N, N,
N-trimethyl ammonium bromide (CTAB, Merck, Germany)
(2). The concentration of the extracted DNA was confirmed
by Nano drop 1000 (NanoDrop, Wilmington, USA).
3.5. Identification of nuc, mecA and pvl genes by the Polymerase
Chain Reaction
Confirmation of all S. aureus isolates was carried out
by PCR for the amplification of nuc gene (279 bp), as done
in the researcher’s previous study (16). The PCR reactions
were performed in a final volume of 25 µL with an auto-
mated thermal cycler (Eppendorf mastercycler gradient,
Germany) using the primers (CinnaGene, Tehran, Iran) for
the nuc gene (Table 1). Negative controls for each primer
contained all components except the template DNA.
The S. aureus isolates were confirmed as MRSA by the
presence of mecA gene (310 bp) among the isolates of S. au-
reus (2).
Amplification of pvl gene (433 bp) among the isolates
of S. aureus was performed according to a study by Lina et
al. (7). Table 1 shows the process and the set of primers used
for the amplification of the above-mentioned genes.
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Table 1. Set of Primers Used in this Study
Primer Sequence (5′→3′) Amplicon Size, bp Target Gene References
nuc/F GCGATTGATGGTGATACGGTT
267 nuc 24
nuc/R AGCCAAGCCTTGACGAACTAAAGC
mecA/F GTAGAAATGACTGAACGTCCGATAA
310 mecA 7
mecA/R CCAATTCCACATTGTTTCGGTCTAA
pvl/F ATCATTAGGTAAAATGTCTGGACATGATCCA
433 pvl 12
pvl/R GCATCAASTGTATTGGATAGCAAAAGC
β ATTGCCTTGATAATAGCCYTCT
937 SCCmec type II, IV 7.26
3α TAAAGGCATCAATGCACAAACACT
ccrC/F CGTCTATTACAAGATGTTAAGGATAAT
518 SCCmec type III, V 7.26
ccrC/R CCTTTATAGACTGGATTATTCAAAATAT
1272F1 GCCACTCATAACATATGGAA
415 SCCmec type I, IV 7.26
1272R1 CATCCGAGTGAAACCCAAA
5RmecA TATACCAAACCCGACAACTAC
359 SCCmec type V 7.26
5R431 CGGCTACAGTGATAACATCC
IVa-F GCCTTATTCGAAGAAACCG
776 SCCmec IVa 27
IVa-R CTACTCTTCTGAAAAGCGTCG
IVb-F TCTGGAATTACTTCAGCTGC
493 SCCmec IVb 27
IVb-R AAACAATATTGCTCTCCCTC
IVc-F ACAATATTTGTATTATCGGAGAGC
200 SCCmec IVc 27
IVc-R TTGGTATGAGGTATTGCTGG
IVd-F5 CTCAAAATACGGACCCCAATACA
881 SCCmec IVd 27
IVd-R6 TGCTCCAGTAATTGCTAAAG
(GTG) GTGGTGGTGGTGGTG - Rep 18
Abbreviations: F, forward; R, reverse.
3.6. Methicillin Resistant Staphylococcus aureus Typing
3.6.1. Amplification of SCCmec by Multiplex PCR
Multiplex PCR was performed for the detection of
SCCmec types I (415 bp), II (937 bp), III (518 bp), IV (937 bp, 415
bp), and V (518 bp, 359 bp) using 5 sets of primers (Table 1),
as previously described (2, 17). The multiplex PCR assay for
SCCmec IV subtypes was carried out using 4 sets of primers
(Table 1), as described previously (18).
3.6.2. Methicillin Resistant Staphylococcus aureus Typing by
Rep-Polymerase Chain Reaction
The Rep-PCR was used for the typing of 87 MRSA iso-
lates with the primer of (GTG) 5 (Table 1), as previously de-
scribed (13, 14). The electrophoresis data were analyzed us-
ing SPSS 22.0 statistical software (SPSS Inc., Chicago, IL).
Dendrogram was built based on Rep-PCR results, using the
algidus interval method, on the basis of the centroid pro-
file.
3.7. Control Strains Used in this Study
Quality control of discs with antibiotics was performed
using S. aureus ATCC 25923, in accordance with the rec-
ommendations of CLSI 2014. The presence of nuc gene
was controlled by S. aureus ATCC 25923 and S. epidermidis
ATCC 12228 as positive and negative control strains, respec-
tively. In the PCR assay for pvl gene, the native isolate
of S. aureus with pvl gene and S. aureus ATCC 25923 were
used as positive and negative controls, respectively. Methi-
cillin resistance was controlled by standard strains: S. au-
reus ATCC 25923 as the negative control and S. aureus ATCC
33591 as the positive control. For the quality control of van-
comycin susceptibility tests, E. faecalis ATCC 29212 and E.
faecalis ATCC 51299 were used as positive and negative con-
trol strains, respectively. All control isolates of MRSA used
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as the positive control for SCCmec typing were kindly pro-
vided by Dr. Mohammad Emaneini (Tehran University of
Medical Science, Iran).
3.8. Statistical Analyses
Data were analyzed by the chi-square test using the
SPSS 22.0 statistical software (SPSS Inc., Chicago, IL). A sta-
tistically significant difference was considered as a P value
of <0.05.
4. Results
4.1. Bacterial Isolation and Confirmation
A total of 215 isolates of S. aureus were collected from
various clinical specimens and identified by standard tests.
Table 2 depicts the source of 215 S. aureus isolates. The ma-
jority of the isolates were obtained from wound and blood
sources.
Table 2. Staphylococcus aureus Isolates and Their Sources, Resistance to Methicillin
and Multi-Drug Resistancea
Type of
Specimen
No. of S. aureus
Isolates (%)
No. of MRSA
Isolates (%)b
MDR (%) in
MRSA Isolates
Wound 80 (37.2) 40 (50) 36 (90)
Blood 38 (16.7) 20 (52.63) 19 (95)
Urine 30 (14) 8 (26.67) 6 (75)
Abscess 20 (9.3) 4 (20) 2 (50)
Sputum 13 (6) 8 (61.54) 8 (100)
CSF 4 (1.9) 3 (75) 3 (100)
Other body
fluids
30 (14) 4 (13.34) 3 (75)
Total 215 (100) 87 (40.5) 77 (88.50)
Abbreviation: MRSA, methicillin-resistant Staphylococcus aureus.
aMulti-drug resistant (isolates which were resistant to 3 and more antimicro-
bial agents, with 88.50% of the MRSA isolates being MDR).
bThe rate of MRSA isolates among 215 Staphylococcus aureus isolates was 40.5%.
4.2. Phenotypic Tests
4.2.1. Antimicrobial Resistance
The results of antimicrobial sensitivity test showed
that all isolates were susceptible to linezolid (100% suscep-
tible) and the majority (96.3%) was resistant to penicillin.
Rates of resistance in MRSA isolates against the studied an-
tibiotics were as follows: penicillin, 100%; oxacillin, 89.7%;
cefoxitin, 96.6%; clindamycin, 88.5%; erythromycin, 86.2%;
ciprofloxacin, 83.9%; gentamicin, 83.9%; trimethoprim-
sulfamethoxazole, 55.17%; and rifampin, 39.08%.
Antibiotic resistance patterns of 87 MRSA isolates are
shown in Table 3. The isolates fell to 10 distinctive antibi-
otic resistance profiles (R1 up to R10). There were 2 major
profiles consisting of 39 (R3) and 26 (R4) isolates (Table 3).
Of the 87 MRSA isolates, 77 isolates (88.50%) were resistant
to more than 3 antimicrobial agents and were recorded as
Multidrug-Resistant (MDR) (Tables 2 and 3).
Table 3. Antibiotic Resistance Patterns of 87 Methicillin Resistant Staphylococcus au-
reus (MRSA) Isolates
Resistance
Patterns
No. (Identity
of Isolates)
Antibiotic
Resistance
Patterns
MDRa or
Non-MDR
R1 4 (14, 75, 111, 119) P, OX, FOX Non-MDR
R2 2 (132, 135) P, OX, FOX, GM,
CC, SXT
MDR
R3 39 (2 - 5, 8, 15, 25,
37, 41, 42, 44, 47,
61-63, 91, 98, 107,
114, 117, 118, 123,
124, 136, 140, 151,
152, 154, 156-158,
160, 162, 173, 175,
176-178, 209)
P, OX, FOX, GM,
CC, E, CP, SXT
MDR
R4 26 (10, 11, 13, 16,
19, 22, 28, 40, 48,
57, 76, 83, 96, 97,
105, 153, 155, 159,
161, 174, 181, 182,
201-203, 206)
P, OX, FOX, GM,
CC, E, CP, R
MDR
R5 6 (60, 68, 74, 78,
125, 179)
P, OX, FOX, GM,
CC, E, CP, SXT, R
MDR
R6 1 (192) P, OX, FOX, CC, E,
CP, R
MDR
R7 1 (7) P, FOX, CC, E, CP,
SXT
MDR
R8 2 (20, 147) P, FOX, CC, E MDR
R9 3 (109, 115, 150) P, FOX Non-MDR
R10 3 (39, 50, 51) P Non-MDR
Abbreviation: CC, clindamycin; CP, ciprofloxacin; FOX, cefoxitin; GM, gen-
tamicin; E, erythromycin; OX, oxacillin; P, penicillin; R, rifampin; SXT,
trimethoprim-sulfamethoxazole.
aMultidrug-resistant (isolates which were resistant to 3 and more antimicro-
bial agents, with 88.50% of the MRSA isolates being MDR).
4.2.2. Agar Screening Methods
By using vancomycin agar screening methods, 3 MRSA
isolates were grown on vancomycin agar screening plates.
Among the 215 S. aureus isolates, 84 were raised on oxacillin
agar screening plates.
4.2.3. Minimum Inhibitory Concentration (by E-Test)
The MIC of isolates against vancomycin was in the
range of 0.25 µg/mL to 6 µg/mL and the MIC50 and MIC90
for the isolates were 0.5 and 1 µg/mL, respectively. Only 3
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MRSA isolates showed MICs equal to 6 µg/mL, which were
previously grown on vancomycin agar screening plates.
These isolates did not fall on the vancomycin resistant cat-
egory, according to CLSI 2014, therefore, they were consid-
ered as vancomycin intermediate-resistant S. aureus (VISA).
The MIC of all S. aureus isolates against oxacillin was
in the range of 0.25 µg/mL to 256 µg/mL. The majority of
MRSA isolates were found to be highly resistant (MIC≥ 256
mg/L) to oxacillin (MIC50 = 256µg/mL; MIC90 = 256µg/mL).
4.3. Methicillin Resistant Staphylococcus aureus Detection
By the combination of genotypic (amplification of
mecA gene) and phenotypic tests (oxacillin and cefoxitin
disk agar diffusion, oxacillin screening agar, and E-test for
oxacillin), 87 (40.5%) isolates were found as MRSA and 128
(59.5%) as MSSA.
There were absolute correlations between the results
of agar screening plates, cefoxitin disk, and E-test in de-
tection of MRSA isolates. By using the above phenotypic
methods, and amplification of mecA gene, 84 and 87 iso-
lates were found as MRSA, respectively. Therefore, 3 mecA-
positive isolates (pre-MRSA or cryptic isolates) could not be
distinguished from the mecA negative isolates by the phe-
notypic tests. The frequency of MRSA isolates is shown in
Table 2 based on the sources of isolation.
4.4. Molecular Tests
4.4.1. Identification of nuc, mecA and pvl Genes
The nuc gene (279 bp) was amplified by all of the iso-
lates. When PCR for mecA gene was performed on S. aureus
isolates, 87 (40.5%) were found as MRSA and 128 (59.5%) as
MSSA.
Of 215 S. aureus isolates, the pvl gene (433 bp fragment)
was detected in 33 (15.35%) of the isolates. Among these, 9
(10.34%) isolates were MRSA and 24 (18.75%) were MSSA (P =
0.093).
4.4.2. Methicillin Resistant Staphylococcus aureus Typing
4.4.2.1. SCCmec Typing
All isolates were typeable with the predominance of
SCCmec type III, which was detected in 69 (79.31%) of the iso-
lates followed by type IV (12, 13.80%) and type I (6, 6.90%)
(Figure 1). All 12 MRSA isolates with SCCmec type IV were
subtyped as SCCmec type IVd.
4.4.2.2. Rep-Polymerase Chain Reaction
By using the Rep-PCR assay, 11 different patterns were
obtained from 87 MRSA isolates with 100% similarity (Fig-
ure 2). There were 2 major clusters consisting of 58 and 17
isolates (indicating their molecular clonality).
Figure 1. SCCmec patterns of Methicillin Resistant Staphylococcus aureus Isolates by
Multiplex Polymerase Chain Reaction
Lanes 1, 3, 7, 9 and 10, clinical isolates with SCCmec type I; lanes 2 and 11, size markers
(1 kb DNA Ladder); lanes 4 and 5, clinical isolates with SCCmec type III; lane 6, clinical
isolate with SCCmec type IV; lanes 8 and 17, size markers (100 bp DNA ladder Plus);
and lanes 12 - 16, control strains (types I - V).
5. Discussion
This study was conducted to investigate antibiotic sus-
ceptibility pattern, frequency, and molecular characteriza-
tion of MRSA isolates in northwest of Iran. The clonal relat-
edness of isolates was also studied.
In the current study, the frequency of MRSA was 40.50%,
which was slightly higher than that reported by similar re-
ports from Iran (36%), similar to that reported by Fatho-
lahzadeh et al. and a previous study by the current re-
searchers conducted during 2005 and 2012 (35.7%) in the
Northwest of Iran (16, 19). However, a higher rate of MRSA
was reported by Sadeghi et al. (56.79%) from the Southeast
of Iran (2). In 2 studies performed in Turkey, the rate of
MRSA was reported as 24.8% and 50.2% (20, 21). In some Eu-
ropean countries, the frequency of MRSA ranged from 0.6%
to 45% and in various locations of Russia, it was between 0%
and 89.5% (20).
Therefore, MRSA rates varied greatly among different
countries, probably reflecting differences in infection con-
trol activities, time of the study, number of cases studied,
and biological characteristics of the MRSA strains (19, 20,
22). On the other hand, this variation in the prevalence of
MRSA around the world emphasized the importance of de-
termining the local prevalence of MRSA, as it could be use-
ful in empiric therapy and its management (19, 20, 22).
In the present study, all isolates were found suscepti-
ble to vancomycin and linezolid, which is compatible with
other published reports (23, 24). This may be due to the de-
crease in the selection pressure for vancomycin antibiotic
and no prescription of linezolid in the studied region.
Oxacillin MIC was more than 256 µg/mL for the ma-
jority of MRSA isolates (MIC50 = 256 µg/mL; MIC90 = 256
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Figure 2. Dendrogram Showing Similarities Between 87 Isolates of Methicillin Re-
sistant Staphylococcus aureus Based on Rep-Polymerase Chain Reaction Data
µg/mL), thus indicating that the corresponding genes
were efficiently expressed (19, 22). These findings could
be due to the irrational antibiotic usage in this region for
treatment and prophylactic purposes.
The SCCmec typing revealed that SCCmec type III was
predominant (69 isolates, 79.31%) among our 87 MRSA iso-
lates, followed by type IVd (12, 13.80%) and type I (6, 6.90%).
The results of this study were in agreement with the
author’s previous findings, showing the predominance
of SCCmec III (69.8%) during 2005 to 2012 in the North-
west of Iran (25). In contrast, in 2 studies conducted by
Moghadami et al. and Zeinali et al. in Iran, the SCCmec
types I and II were found to be more prevalent, respectively
(4, 26). The predominance of type III in the current study
could be because MRSA isolates descended from a com-
mon origin, indicating the presence of clonality among
the MRSA isolates (2, 4, 22).
Therefore, in the areas with inappropriate and high
rate of antibiotic use, such as healthcare facilities, MRSA
strains have been shown to gain diverse types of SCCmec
elements and this variation emphasizes the importance of
determining local prevalence of SCCmec type, which could
be useful in the management of patients (2, 6).
Based on the current data, the majority of MRSA iso-
lates carrying SCCmec type III (66, 96%) showed an MDR
phenotype. In the current study, SCCmec typing was corre-
lated well with major antimicrobial susceptibility patterns
(R3 and R4).
Panton-valentine Leukocidin is an important factor as-
sociated with severe infections and the occurrence of PVL
in S. aureus strains is increasing due to the global distri-
bution of PVL-producing strains. The worldwide spread of
PVL-positive MRSA and variation in the prevalence of these
strains around the world emphasizes the importance of
determining the local prevalence of PVL-positive MRSA, as
it could be useful in empiric therapy and its management
(2, 5-7). In the current study, 33 (15.35%) S. aureus isolates
were PVL-positive. In a study from Iran, a low frequency
of S. aureus isolates (3.08%) were PVL-positive (2), while in
another research, a high number of isolates (24.20%) were
reported as PVL-positive (8). The high rate of PVL-positive
isolates in the present study is an alarm to clinicians, en-
couraging proper therapy in this region.
The emergence of vancomycin intermediate-resistant
S. aureus is a great concern and alarm to clinicians in find-
ing an alternative treatment.
A total of 11 Rep patterns, including 2 main clusters
were obtained from 87 MRSA isolates that were 100% sim-
ilar, indicating their molecular clonality and shared ori-
gins. Therefore, routine infection controls surveillance
could be necessary for the prevention of epidemic emer-
gence. The current findings were in agreement with the
results of some previous studies (2, 11, 14).
According to analyzed data, Rep-PCR patterns [pres-
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ence of 2 major cluster, (Figure 2)] correlated well with
SCCmec typing results (predominantly those carrying
SCCmec type III) and antimicrobial susceptibility profiles
(major antimicrobial susceptibility patterns were R3 and
R4), confirming the presence of clonality in the studied
MRSA isolates.
5.1. Conclusions
The current findings showed that the frequency of
MRSA isolates was relatively high in the North West of
Iran; those carrying the SCCmec type III were multidrug-
resistant. Linezolid and vancomycin could be suitable an-
tibiotics in the treatment of infections caused by these
multi-resistant pathogens. There was good correlation be-
tween the results of Rep analysis, SCCmec typing and an-
tibiotic resistance, indicating a common origin and clonal-
ity among the MRSA isolates. Therefore, routine infection
control surveillance could be necessary for the prevention
of epidemic emergence.
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